MétaCan
Menu
← Back to cohort
Record W2312621489 · doi:10.1158/0008-5472.sabcs-2103

Assessment of barriers to patient participation in clinical trials among oncology outpatients at a community teaching hospital in Toronto.

2009· article· en· W2312621489 on OpenAlexaffabout
Leanne Shamrakov, Heather Sampson, Joyce Nyhof‐Young, Y Rahim

Bibliographic record

VenueCancer Research · 2009
Typearticle
Languageen
FieldMedicine
TopicEthics in Clinical Research
Canadian institutionsUniversity of TorontoPrincess Margaret Cancer CentreToronto East General Hospital
Fundersnot available
KeywordsMedicineClinical trialFamily medicineThematic analysisCuriosityAlternative medicineLikert scaleDescriptive statisticsTest (biology)Internal medicinePsychologyQualitative researchPathologySocial psychology

Abstract

fetched live from OpenAlex

Abstract Abstract #2103 Background: This study investigated barriers to patient participation in clinical trials (CTs). In particular, the effect of educational attainment on the understanding of, interest about, and past participation in CTs among cancer patients at a Toronto community teaching hospital was assessed. Material and Methods: A survey was administered to cancer outpatients, containing Yes/No answers, Likert scales and written response answers. Responses were analyzed quantitatively (SPSS) and qualitatively (constant comparison, descriptive thematic analysis). Results: 101 questionnaires were completed out of 112 administered (90% response rate). 76% of patients self-reported as knowledgeable about clinical trials. Patients' education level correlated to their perceived knowledge of clinical trials:37.5% of patients with a less than grade 9, 59.4% with a high school, and 90.2% with a university background identified themselves as knowing what CTs are. All patients scored poorly on details and held common misconceptions of CTs (e.g. knowing little about placebos and experimental drug testing). Overall, 27% of patients had been previously enrolled in CTs. Of the 34% of patients who had been previously approached, 79% had agreed to participate. This result is higher than figures reported in literature, and slightly higher than a recent Canadian study at an academic center. The majority were willing to participate or unsure of participating in CTs. A minority stated they will never participate in a trial. Patients identified altruism, curiosity, personal benefit, alleviation of financial burdens, last resort treatment, and a desire to contribute to medicine as participation motivators. They identified unknown side effects, and risk of illness or death as reasons to decline. These concerns were consistent with previous studies. Patients also identified concern about lack of hospital resources about CTs and a desire to have a doctor present when learning about CTs. Patients with less education identify a greater desire for a doctor's presence than those with more education. Discussion: This study revealed lack of staff recruitment, low patient awareness, and lack of availability of trial facilities as potential barriers to participation. Targeted information to patients with different education levels may be appropriate, given variable knowledge about CTs. Education and counseling regarding placebos and experimental drugs should be targeted towards all patients to reduce barriers to patient participation, diminish myths, and increase understanding and interest. In response, this institution will design a brochure for all patients explaining and describing clinical trials, providing a glossary of terms, and offering a list of key resources. Availability of such information at oncology centers will in turn improve awareness and trial recruitment. Citation Information: Cancer Res 2009;69(2 Suppl):Abstract nr 2103.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.014
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: Methods · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.996
Threshold uncertainty score0.421

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.014
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0020.001
Scholarly communication0.0010.000
Open science0.0010.001
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0050.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.705
GPT teacher head0.759
Teacher spread0.054 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designObservational
DomainMethods
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2009
Admission routes2
Has abstractyes

Explore more

Same venueCancer Research→Same topicEthics in Clinical Research→French-language works237,207→